Interleukin-1 stimulates prostacyclin production by cultured human endothelial cells by increasing arachidonic acid mobilization and conversion

Arteriosclerosis. 1990 Jan-Feb;10(1):129-34. doi: 10.1161/01.atv.10.1.129.

Abstract

Interleukin-1 (IL-1) induced slow, lasting activation of human endothelial cells (EC) to release prostacyclin (PGI2). This was accompanied by endogenous 3H-arachidonic acid (3H-AA) release and by a time-dependent increase in the cells' ability to convert exogenous AA. The continuous presence of IL-1 was not required, but about a 1-hour stimulation with the cytokine was sufficient to trigger the cells to synthesize PGI2 for several hours. The spectrum of 3H-AA conversion shows that, in addition to 6-keto-prostaglandin F1 alpha, prostaglandin F2 alpha also was raised after IL-1. The recovery of PGI2 synthesis after aspirin was faster in IL-1-treated EC than in control cells. These data define some of the characteristics of IL-1 stimulation of PGI2 and suggest that this process is mediated both by endogenous AA mobilization and by an increase in cyclooxygenase activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / metabolism
  • Arachidonic Acid
  • Arachidonic Acids / metabolism*
  • Aspirin / pharmacology
  • Cells, Cultured
  • Endothelium, Vascular / metabolism*
  • Epoprostenol / biosynthesis*
  • Humans
  • In Vitro Techniques
  • Interleukin-1 / pharmacology
  • Prostaglandin-Endoperoxide Synthases / metabolism

Substances

  • Arachidonic Acids
  • Interleukin-1
  • Arachidonic Acid
  • 6-Ketoprostaglandin F1 alpha
  • Epoprostenol
  • Prostaglandin-Endoperoxide Synthases
  • Aspirin